Showing results (91-100 of 170) with videos related to

Sort By:
Pageof 17
PLOS Global Public Health|March 16, 2026
Quality assessment of data for decentralised antiretroviral therapy referrals and laboratory results in the South African national electronic HIV management register TIER.NetLisanthini Naidu, Johan van der Molen, Vishen Jugathpal, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 12, 2022
Diagnostic Accuracy of the Rapid Xpert HIV-1 Viral Load XC, Xpert HIV-1 Viral Load, & m-PIMA HIV-1/2 Viral Load in South African ClinicsJienchi Dorward, Jessica Naidoo, Pravikrishnen Moodley, et al.
Open Forum Infectious Diseases|September 22, 2025
Uptake and 24-month Outcomes of Dolutegravir- Versus Lopinavir-based Second-line Antiretroviral Therapy for People With HIV in South Africa: A Retrospective Cohort Study and Emulated Target TrialJennifer Anne Brown, Lara Lewis, Yukteshwar Sookrajh, et al.
Plos Pathogens|April 9, 2026
Cell-free RNA reveals host and microbial correlates of broadly neutralizing antibody development against HIVMark Kowarsky, Mercedes Dalman, Mira N Moufarrej, et al.
BMJ Global Health|April 9, 2025
Impact of increasing CD4 count threshold eligibility for antiretroviral therapy initiation on advanced HIV disease and tuberculosis prevalence and incidence in South Africa: an interrupted time series analysisKwabena Asare, Lara Lewis, Johan van der Molen, et al.
Plos Pathogens|December 17, 2019
IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibodySimone I Richardson, Bronwen E Lambson, Andrew R Crowley, et al.
Southern African Journal of HIV Medicine|December 8, 2022
Erratum: Southern African HIV Clinicians Society 2022 guideline for the management of sexually transmitted infections: Moving towards best practiceRemco P H Peters, Nigel Garrett, Nomathemba Chandiwana, et al.
Sexually Transmitted Infections|November 18, 2024
High burden of human papillomavirus and premalignant cervical lesions among women starting HIV treatment in KwaZulu-Natal, South AfricaNivashnee Naicker, Farzana Osman, Kunthi Naidoo, et al.
BMJ Open|February 17, 2021
Protocol for a randomised feasibility study of Point-Of-care HIV viral load testing to Enhance Re-suppression in South Africa: the POwER studyJienchi Dorward, Yukteshwar Sookrajh, Hope Ngobese, et al.
BMJ Open|July 6, 2019
Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trialSharana Mahomed, Nigel Garrett, Edmund Capparelli, et al.
Pageof 17